Skip to Main Content

Paper Details

Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.
Breast Cancer Res Treat
7
2015
57 genes, CK5/6, DNA, EGFR proteins, ER, ER-positive, ER-positive breast cancer, ER-positive breast cancers, ER-positive low MEI cancers, HER2, MEI, Methylation markers, PR, breast cancer, cancers, gene, invasive tumors, mRNA, methylation, methylation markers, patients, women
Adult, Aged, Biomarkers, Tumor, Breast Neoplasms, Case-Control Studies, DNA Methylation, Disease-Free Survival, Female, Gene Expression, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Middle Aged, Prognosis, Proportional Hazards Models, RNA, Messenger, Receptors, Estrogen, Young Adult
Author NameAffiliation
Jonine D FigueroaNational Cancer Institute
Jonine D FigueroaNational Cancer Institute
Howard H YangNational Cancer Institute
Howard H YangNational Cancer Institute
Montserrat Garcia-ClosasInstitute for Cancer Research
Montserrat Garcia-ClosasInstitute for Cancer Research
Sean DavisNational Cancer Institute
Susan R DavisNational Cancer Institute
Paul S MeltzerNational Cancer Institute
Paul S MeltzerNational Cancer Institute
Jolanta LissowskaCancer Center and M. Sklodowska-Curie Institute of Oncology
Jolanta LissowskaCancer Center and M. Sklodowska-Curie Institute of Oncology
Hisani N HorneNational Cancer Institute
Hisani N HorneNational Cancer Institute
Mark E ShermanNational Cancer Institute
Mark E ShermanNational Cancer Institute
Maxwell P LeeNational Cancer Institute
Maxwell P LeeNational Cancer Institute
  • 1 - 18

Datasets

Release 1.2